-
The Gut-Brain Axis in Alzheimer’s: From Microbiota Genetics to Stigmasterol’s Neuroprotection Mechanism
-
Effectiveness of Electroconvulsive Therapy in the Remission of Malignant Catatonia Associated With Schizophrenia: A Case Report
-
Curcumin and an antioxidant formulation protect C57BL/6J mice from MPTP-induced Parkinson’s disease like changes: potential neuroprotection for neurodegeneration
-
The Global Burden of Schizophrenia: Findings from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study
-
An excitement building in the development of psychological treatments for schizophrenia
-
The new German evidence‐ and consensus‐based schizophrenia guideline
-
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia
-
Pilot Study of Behavioral Activation Treatment for Negative Symptoms in Older Adults With Schizophrenia Spectrum Disorder
-
What does it take to make real‐world changes in schizophrenia care?
-
Towards an integrative and personalized care across the stages of schizophrenia spectrum disorders
-
Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying
-
The problem of recognition of clinical high‐risk states is hampering the prevention of schizophrenia
-
Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review
-
Nuances of Gender Identity for a Transgender Patient Receiving Inpatient Treatment for Paranoid Schizophrenia: A Case Study
-
Associations Between Serum Adipokine, Antipsychotic Exposure, and Clinical Characteristics in Chronic Schizophrenia: A Cross‐Sectional Study
-
Aerobic Exercise for Cognitive and Functional Enhancement in Schizophrenia: Evidence, Mechanisms, and Practical Recommendations
-
Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia
-
Quality of Life After Psychosis: Surviving Schizophrenia and Making a Full Emotional Recovery
-
Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case Report
-
A Systematic Review of the Magnetic Resonance Imaging Literature Investigating the Deficit Syndrome in Schizophrenia
-
Animal models of Parkinson's disease and their applications
-
Attitudes Driving Regional Differences in Long-Acting Injectable Antipsychotic Utilization for Schizophrenia among Healthcare Professionals, Patients, and Caregivers (ADVANCE): Results from a Multinational Survey Study
-
Effects of Repeated Smoking and Quitting Cigarettes on Plasma Concentrations of Clozapine and Its N‐Desmethyl and N‐Oxide Metabolites in a Japanese Patient With Schizophrenia
-
Association Between Frontotemporal Atrophy and Cognitive Impairment in Patients with Schizophrenia Based on Computed Tomography Imaging
